As we were unable to test whether Lef1 deletion attenuated tumorigenesis in our mice, defining this will be a priority, particularly given that Lef1 ablation in a murine intestinal tumour model unexpectedly increased tumour development (Heino et al, 2021). The gene discussed is LEF1; the disease is neoplasm.